Zhu Zhuoting, Hu Wenyi, Liao Huan, Tan Zachary, Chen Yifan, Shi Danli, Shang Xianwen, Zhang Xueli, Huang Yu, Yu Honghua, Wang Wei, He Mingguang, Yang Xiaohong
Department of Ophthalmology, Guangdong Academy of Medical Sciences, Guangdong Provincial People's Hospital, Guangzhou, China.
Shanghai Jiaotong University, Shanghai, China.
EClinicalMedicine. 2021 Nov 6;42:101189. doi: 10.1016/j.eclinm.2021.101189. eCollection 2021 Dec.
Although visual dysfunction is one of the most common non-motor symptoms among patients with Parkinson's disease (PD), it is not known whether visual impairment (VI) predates the onset of clinical PD. Therefore, we aim to examine the association of VI with the future development of PD in the UK Biobank Study.
The UK Biobank Study is one of the largest cohort studies of health, enrolling over 500,000 participants aged 40-69 years between 2006 and 2010 across the UK. VI was defined as a habitual distance visual acuity (VA) worse than 0·3 logarithm of the minimum angle of resolution (LogMAR) in the better-seeing eye. Incident cases of PD were determined by self report data, hospital admission records or death records, whichever came first. Multivariable Cox proportional hazard regression models were used to investigate the association between VI and the risk of incident PD.
A total of 117,050 participants were free of PD at the baseline assessment. During the median observation period of 5·96 (IQR: 5·77-6·23) years, PD occurred in 222 (0·19%) participants. Visually impaired participants were at a higher risk of developing PD than non-VI participants ( < 0·001). Compared with the non-VI group, the adjusted hazard ratio was 2·28 (95% CI 1·29-4·05, = 0·005) in the VI group. These results were consistent in the sensitivity analysis, where incident PD cases diagnosed within one year after the baseline assessment were excluded.
This cohort study found that VI was associated with an increased risk of incident PD, suggesting that VI may serve as a modifiable risk factor for prevention of future PD.
尽管视觉功能障碍是帕金森病(PD)患者中最常见的非运动症状之一,但尚不清楚视力损害(VI)是否早于临床PD的发病。因此,我们旨在通过英国生物银行研究来探讨VI与PD未来发病之间的关联。
英国生物银行研究是最大的健康队列研究之一,在2006年至2010年间招募了超过50万名年龄在40 - 69岁之间的英国参与者。VI被定义为较好眼的习惯性远视力(VA)低于0·3最小分辨角对数(LogMAR)。PD的新发病例通过自我报告数据、住院记录或死亡记录来确定,以最早出现的为准。使用多变量Cox比例风险回归模型来研究VI与PD发病风险之间的关联。
在基线评估时,共有117,050名参与者无PD。在中位观察期5·96(四分位间距:5·77 - 6·23)年期间,222名(0·19%)参与者发生了PD。视力受损的参与者比非VI参与者发生PD的风险更高(<0·001)。与非VI组相比,VI组的调整后风险比为2·28(95%置信区间1·29 - 4·05,=0·005)。在敏感性分析中排除基线评估后一年内诊断出的PD新发病例,这些结果仍然一致。
这项队列研究发现VI与PD发病风险增加有关,表明VI可能是预防未来PD的一个可改变的风险因素。